Patents Assigned to Oscient Pharmaceuticals Corporation
  • Patent number: 7129214
    Abstract: Compounds of the formula (I) where Ar and R are as defined herein, possess antibacterial properties.
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: October 31, 2006
    Assignee: Oscient Pharmaceuticals Corporation
    Inventors: Wenhao Hu, Roland W. Bürli
  • Patent number: 7090973
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Bacteroides fragilis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: August 15, 2006
    Assignee: Oscient Pharmaceuticals Corporation
    Inventor: Gary L. Breton
  • Publication number: 20050004042
    Abstract: Compounds of the formula (I) where Ar and R are as defined herein, possess antibacterial properties.
    Type: Application
    Filed: December 9, 2003
    Publication date: January 6, 2005
    Applicant: Oscient Pharmaceuticals Corporation
    Inventors: Wenhao Hu, Roland Burli